Description de l'entreprise
Our mission is to build the first next-generation biotechnology company – one that expands the highest quality therapies to more people around the world – through courage, persistent innovation, and challenging the status quo. Our values – patients first, bold ingenuity, collaborative spirit, and driving excellence- are the foundation of what we stand for.
Conseil d'administration & Conseil de surveillance
| PDG |
| - |
| Conseil d'administration |
| - |
| Conseil de surveillance |
| - |
Données de l'entreprise
| Nom: |
BeiGene Ltd |
| Adresse: |
55 Cambridge Parkway, Suite 700W,Cambridge |
| Téléphone: |
+1 (781) 801-1800 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
https://www.beigene.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
89.70% |
| IPO date: |
01/02/2016 |
Relations avec les investisseurs
| Nom: |
- |
| Téléphone IR: |
+1857-302-5189 |
| IR-Fax: |
- |
| E-mail IR: |
ir@beigene.com
|
